Minimising time-to-market in priority countries for newly registered MMV products
Driving acceptance, availability and uptake of appropriate malaria medicines in endemic countries
Ensuring timely availability of key market data to inform product development, launch and scale up
Aligning product development criteria and clinical trial design with specific unmet needs